Literature DB >> 2382447

[The treatment of blepharospasm with botulinum toxin A].

P Költringer1, H Haselwander, F Reisecker.   

Abstract

12 patients suffering from essential blepharospasm were treated by injection of 4 ng botulinum toxin A into the Musculus orbicularis oculi of each eye. The effect was followed up over a period of 6 weeks by means of a subjective rating scale, a visual function score and a score for the overall clinical impression. After 4 days an improvement was observed in all patients and it was still present after 6 weeks. After a time interval of 12 weeks reinjection was performed in 8 cases with half the initial dose, since the beneficial effect had decreased to under 50%. Follow-up showed an impressive response to reinjection of botulinum toxin A, which remained undiminished still after 6 weeks. No serious side effects were observed. Hence, this form of therapy appears to be an effective alternative to all other therapeutic measures in this disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382447

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  1 in total

1.  Botulinum toxin injections for blepharospasm prior to ocular surgeries.

Authors:  Seydi Okumus; Erol Coskun; Ibrahim Erbagci; M Gürkan Tatar; Aysegul Comez; Erdal Kaydu; Ramazan Yayuspayi; Bulent Gurler
Journal:  Clin Ophthalmol       Date:  2012-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.